<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03729232</url>
  </required_header>
  <id_info>
    <org_study_id>M28-114</org_study_id>
    <secondary_id>UMIN000028288</secondary_id>
    <nct_id>NCT03729232</nct_id>
  </id_info>
  <brief_title>Japanese Catheter Ablation Registry</brief_title>
  <acronym>J-AB</acronym>
  <official_title>Japanese Catheter Ablation Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cerebral and Cardiovascular Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cerebral and Cardiovascular Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Japanese Cather Ablation (J-AB) Registry is a voluntary nationwide registry, performed by
      Japanese Heart Rhythm Society, collaborated with the National Cerebral and Cardiovascular
      Center. The objectives of this registry are to observe and describe developments in the
      catheter ablation treatment of arrhythmia in Japan and to provide reliable information on the
      type of activity performed and the facilities available in Japanese arrhythmia units.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Japanese Cather Ablation (J-AB) Registry is a nationwide, multicenter, observational
      registry, performed by Japanese Heart Rhythm Society, collaborated with National Cerebral and
      Cardiovascular Center.

      This study is a voluntary nationwide registry and data are collected prospectively using a
      Research Electronic Data Capture (REDCap) system. Detailed data collection including
      antiarrhythmic medication is also performed at every September. The acute success rate at
      discharge and the complications associated with ablation procedure will be collected in all
      cases. Major bleeding events are defined according to Bleeding Academic Research Consortium
      criteria. Based on the provided information, the annual incidence and predictive factors for
      outcome will be investigated by the event assessment committee.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Anticipated">March 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with recurrence of targeted arrhythmia</measure>
    <time_frame>Through discharge from hospital, approximately up to 1 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of deaths</measure>
    <time_frame>Through discharge from hospital, approximately up to 1 weeks</time_frame>
    <description>All-cause death, cardiovascular death, and procedure-related death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with treatment-related complications</measure>
    <time_frame>3 months</time_frame>
    <description>Bleeding events, embolic events, other all complications. Major bleeding events are defined according to Bleeding Academic Research Consortium criteria.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">400000</enrollment>
  <condition>Catheter Ablation</condition>
  <condition>Cardiac Arrhythmias</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Inpatients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients treated with catheter ablation in Japan

        Exclusion Criteria:

          -  Patients who refused to consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Teiichi Yamane, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Jikei University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kengo Kusano, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cerebral and Cardiovascular Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kengo Kusano, MD, PhD</last_name>
    <phone>+81-6-6170-1070</phone>
    <email>kusanokengo@ncvc.go.jp</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Misa Takegami, PhD, MPH</last_name>
    <phone>+81-6-6170-1070</phone>
    <email>takegami@ncvc.go.jp</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Cerebral and Cardiovascular Center</name>
      <address>
        <city>Suita</city>
        <state>Osaka</state>
        <zip>564-8565</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kengo Kusano, MD, PhD</last_name>
      <phone>+81-6-6170-1070</phone>
      <email>kusanokengo@ncvc.go.jp</email>
    </contact>
    <contact_backup>
      <last_name>Misa Takegami, PhD, MPH</last_name>
      <phone>+81-6-6170-1070</phone>
      <email>takegami@ncvc.go.jp</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>October 31, 2018</study_first_submitted>
  <study_first_submitted_qc>November 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2018</study_first_posted>
  <last_update_submitted>April 10, 2020</last_update_submitted>
  <last_update_submitted_qc>April 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cerebral and Cardiovascular Center</investigator_affiliation>
    <investigator_full_name>Kengo Kusano</investigator_full_name>
    <investigator_title>Director of Cardiovascular Medicine, National Cerebral and Cardiovascular Center</investigator_title>
  </responsible_party>
  <keyword>Catheter Ablation</keyword>
  <keyword>Cardiac Arrhythmias</keyword>
  <keyword>Registry</keyword>
  <keyword>Complication</keyword>
  <keyword>REDCap</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

